The Net Margin of Lineage Cell Therapeutics Inc (LCTX) is -436.47%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | -436.47% |
| 2024-12-31 | -195.90% |
| 2023-12-31 | -240.20% |